Pirfenidone inhibits <scp>TGF‐β1‐induced</scp> metabolic reprogramming during <scp>epithelial‐mesenchymal</scp> transition in <scp>non‐small</scp> cell lung cancer
Journal of Cellular and Molecular Medicine